Inhibiting COMT in Parkinson’s Disease
Condition(s):Parkinson’s DiseaseLast Updated:January 25, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):Parkinson’s DiseaseLast Updated:January 25, 2021Withdrawn
Condition(s):Parkinson’s DiseaseLast Updated:July 11, 2014Terminated
Condition(s):Parkinson DiseaseLast Updated:March 27, 2017Completed
Condition(s):Advanced Parkinson DiseaseLast Updated:June 13, 2023Recruiting
Condition(s):Parkinson DiseaseLast Updated:August 20, 2015Completed
Condition(s):Tachycardia; Chronic Orthostatic IntoleranceLast Updated:September 22, 2023Active, not recruiting
Condition(s):Parkinson’s DiseaseLast Updated:July 13, 2016Completed
Condition(s):SchizophreniaLast Updated:September 27, 2018Terminated
Condition(s):Parkinson’s DiseaseLast Updated:November 21, 2013Completed
Condition(s):Parkinson’s Disease; Parkinsonian Disorders; Atypical Parkinson Disease; Progressive Supranuclear Palsy; Multiple System Atrophy; Corticobasal Degeneration; Gait, Frontal; Huntington DiseaseLast Updated:January 4, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.